Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Legood

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|January 24, 2018
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population WomenRanjit Manchanda, Shreeya Patel, Vladimir S Gordeev, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 5, 2022
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomesMatthew Burnell, Faiza Gaba, Monika Sobocan, et al.
JAMA Network Open|February 9, 2024
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast CancerXia Wei, Li Sun, Eric Slade, et al.
American Journal of Obstetrics and Gynecology|April 25, 2025
Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysisAshwin Kalra, Subhasheenee Ganesan, Jacqueline J Y Sia, et al.
Cancers|July 26, 2020
Economic Evaluation of Population-Based <i>BRCA1/BRCA2</i> Mutation Testing across Multiple Countries and Health SystemsRanjit Manchanda, Li Sun, Shreeya Patel, et al.
Journal of Medical Genetics|March 20, 2016
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutationsRanjit Manchanda, Matthew Burnell, Kelly Loggenberg, et al.
Journal of the National Cancer Institute|December 2, 2014
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingRanjit Manchanda, Rosa Legood, Matthew Burnell, et al.
JAMA Oncology|October 4, 2019
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast CancerLi Sun, Adam Brentnall, Shreeya Patel, et al.
Cancers|February 25, 2023
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UKSamuel Oxley, Ashwin Kalra, Michail Sideris, et al.
JAMA Network Open|September 16, 2025
Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian CancerJacqueline Sia, Emily F Lane, Caitlin T Fierheller, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|January 24, 2018
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population WomenRanjit Manchanda, Shreeya Patel, Vladimir S Gordeev, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 5, 2022
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomesMatthew Burnell, Faiza Gaba, Monika Sobocan, et al.
JAMA Network Open|February 9, 2024
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast CancerXia Wei, Li Sun, Eric Slade, et al.
American Journal of Obstetrics and Gynecology|April 25, 2025
Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysisAshwin Kalra, Subhasheenee Ganesan, Jacqueline J Y Sia, et al.
Cancers|July 26, 2020
Economic Evaluation of Population-Based <i>BRCA1/BRCA2</i> Mutation Testing across Multiple Countries and Health SystemsRanjit Manchanda, Li Sun, Shreeya Patel, et al.
Journal of Medical Genetics|March 20, 2016
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutationsRanjit Manchanda, Matthew Burnell, Kelly Loggenberg, et al.
Journal of the National Cancer Institute|December 2, 2014
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingRanjit Manchanda, Rosa Legood, Matthew Burnell, et al.
JAMA Oncology|October 4, 2019
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast CancerLi Sun, Adam Brentnall, Shreeya Patel, et al.
Cancers|February 25, 2023
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UKSamuel Oxley, Ashwin Kalra, Michail Sideris, et al.
JAMA Network Open|September 16, 2025
Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian CancerJacqueline Sia, Emily F Lane, Caitlin T Fierheller, et al.
Pageof 9